Multilevel Intervention for LDCT Lung Cancer Screening and Smoking Cessation Among African Americans

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age50-80
SponsorLouisiana State University Health Sciences Center in New Orleans

About this trial

This study aims to reduce disparities and the burden of lung cancer among African American smokers by supporting a Multiple-level intervention integrating lung cancer screening and smoking cessation (MILS), followed the NIH DEIA strategies using multilevel interventions that impact determinants of health and address health disparities at appropriate time points across the life course.

Eligibility criteria

Qualifiers

African American

20+ pack years of smoking

eligible for or received LDCT screening

current smoker

Disqualifiers

N/A

Trial design

Treatments tested in this trial

  • Smoking cessation multilevel Intervention

Treatment groups

250 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Louisiana State University Health Sciences Center in New Orleans

Lead sponsor

National Institute on Minority Health and Health Disparities (NIMHD)

Collaborator